[go: up one dir, main page]

FI970143A0 - Quinoline derivatives as leukotriene antagonists - Google Patents

Quinoline derivatives as leukotriene antagonists

Info

Publication number
FI970143A0
FI970143A0 FI970143A FI970143A FI970143A0 FI 970143 A0 FI970143 A0 FI 970143A0 FI 970143 A FI970143 A FI 970143A FI 970143 A FI970143 A FI 970143A FI 970143 A0 FI970143 A0 FI 970143A0
Authority
FI
Finland
Prior art keywords
quinoline derivatives
leukotriene antagonists
leukotriene
antagonists
quinoline
Prior art date
Application number
FI970143A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI970143A7 (en
Inventor
Dorte Kirstein
Schneur Rachlin
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI970143A7 publication Critical patent/FI970143A7/en
Publication of FI970143A0 publication Critical patent/FI970143A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
FI970143A 1994-07-20 1997-01-14 Quinoline derivatives as leukotriene antagonists FI970143A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414590A GB9414590D0 (en) 1994-07-20 1994-07-20 Chemical compounds
PCT/DK1995/000223 WO1996002506A1 (en) 1994-07-20 1995-06-07 Quinoline derivatives as leukotriene antagonists

Publications (2)

Publication Number Publication Date
FI970143A7 FI970143A7 (en) 1997-01-14
FI970143A0 true FI970143A0 (en) 1997-01-14

Family

ID=10758585

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970143A FI970143A0 (en) 1994-07-20 1997-01-14 Quinoline derivatives as leukotriene antagonists

Country Status (13)

Country Link
EP (1) EP0773931A1 (en)
JP (1) JPH10504026A (en)
KR (1) KR970704691A (en)
CN (1) CN1152915A (en)
AU (1) AU686820B2 (en)
CA (1) CA2192478A1 (en)
CZ (1) CZ284799B6 (en)
FI (1) FI970143A0 (en)
GB (1) GB9414590D0 (en)
HU (2) HUT76443A (en)
NZ (1) NZ287850A (en)
PL (1) PL318106A1 (en)
WO (1) WO1996002506A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761687B1 (en) 1997-04-08 2000-09-15 Centre Nat Rech Scient QUINOLEIN DERIVATIVES, ESPECIALLY HAVING ANTIVIRAL PROPERTIES, THEIR PREPARATIONS AND THEIR BIOLOGICAL APPLICATIONS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728051D0 (en) * 1987-12-01 1988-01-06 Leo Pharm Prod Ltd Chemical compounds
US4918081A (en) * 1988-06-20 1990-04-17 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene d4
GB9216768D0 (en) * 1992-08-07 1992-09-23 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
GB9414590D0 (en) 1994-09-07
FI970143A7 (en) 1997-01-14
CZ284799B6 (en) 1999-03-17
CA2192478A1 (en) 1996-02-01
JPH10504026A (en) 1998-04-14
AU2669695A (en) 1996-02-16
PL318106A1 (en) 1997-05-12
HU9603342D0 (en) 1997-01-28
WO1996002506A1 (en) 1996-02-01
NZ287850A (en) 1998-05-27
CN1152915A (en) 1997-06-25
EP0773931A1 (en) 1997-05-21
AU686820B2 (en) 1998-02-12
CZ352996A3 (en) 1997-10-15
HUT76443A (en) 1997-09-29
KR970704691A (en) 1997-09-06

Similar Documents

Publication Publication Date Title
FI944734A7 (en) Quinoline derivatives as leukotriene antagonists
NO965036D0 (en) Quinoline derivatives such as techykinin NK3 receptor antagonists
NO20013003D0 (en) Quinoline derivatives
ATE228505T1 (en) QUINOLINE DERIVATIVES
ATE240327T1 (en) 1,2-ANNELATED QUINOLINE DERIVATIVES
IS5775A (en) Quinoline derivatives
ATE289994T1 (en) QUINOLINE DERIVATIVES
FI970310L (en) 4-Indole derivatives as serotonin agonists and antagonists
ATE229005T1 (en) QUINOLINE DERIVATIVES
DK0922034T3 (en) Tetrahydroquinoline derivatives as EAA antagonists
FI961628A7 (en) Indole derivatives as NMDA antagonists
NO974043D0 (en) Indole derivatives as EAA antagonists
DK0854867T3 (en) Tetrahydroquinolines as NMDA Antagonists
DK1216250T3 (en) Thienoisoxazolyl and thienylpyrazolyl-phenoxy-substituted propyl derivatives as D4 antagonists
NO962717D0 (en) Diaryl-5,6-fused heterocyclic acids as leukotriene antagonists
DK1086093T3 (en) Tetrahydroquinoline derivatives as glycine antagonists
FI970745A7 (en) Dihydropyridine derivatives as bradykinin antagonists
FI971492L (en) Indole derivatives as 5-HT1-type agonists
FI970143A0 (en) Quinoline derivatives as leukotriene antagonists
NO983656D0 (en) Heterocyclyl-ergoline derivatives as 5-HT1A receptor ligands
DE69515498D1 (en) NAPHTHYRIDINE DERIVATIVES
KR950700884A (en) Quinoline derivatives as leukotriene antagonists
FI970827A7 (en) New thiazolo 3,2-a/quinoline and -naphthyridine derivatives
NO920022L (en) Saturated Hydroxyalkyl Quinoline Acids as Leukotriene Antagonists
ITMI941098A0 (en) QUINOLINE DERIVATIVES